Letter Sequence Other |
---|
|
Results
Other: ML070440355, ML070440356, ML070440358, ML070440359, ML070440402, ML070440406, ML070680341, ML071020291, ML071020319, ML071020383, ML071020483, ML071020505, ML071030021, ML071030022, ML071030042, ML071030069, ML071030191, ML071030211, ML071030221, ML071200177, ML071200179, ML071200187, ML071200188, ML071200197, ML071240467, ML071240473, ML071280766, ML071280811, ML071280814, ML071290120, ML071290155, ML071290298, ML071290387, ML071560466, ML071560469, ML071560479, ML071570036, ML071570037, ML071570049, ML071570052, ML071570059, ML071570063, ML071570118, ML071570122, ML071570124, ML071580958, ML071580962, ML071580965, ML071580976, ML071580981... further results
|
MONTHYEARML0712901552006-05-0909 May 2006 (NPA-PD) Letter to Mary Lampert from the Commonwealth of Massachusetts Executive Office of Heath and Human Services, Department of Public Health, Regarding Child Heath Statistics Project stage: Other ML0704403592007-01-0404 January 2007 E-MAIL: (PD) FW: Pilgrim in the News Project stage: Other ML0715700492007-01-16016 January 2007 Budget Presentation,Town of Plymouth Fiscal Year 2008 Budget Primer. Project stage: Other ML0704403952007-01-18018 January 2007 E-mail: (PD) Upcoming Pilgrim Environmental License Renewal Meeting Project stage: Meeting ML0705301852007-01-24024 January 2007 Draft Environmental Impact Statement Public Meeting, January 24, 2007, Evening Transcript-Corrected Project stage: Request ML0705301892007-01-24024 January 2007 Draft Environmental Impact Statement Public Meeting, January 24, 2007, Afternoon Transcript-Corrected Project stage: Request ML0706003092007-01-24024 January 2007 Attachments to Pilgrim Draft Environmental Impact Statement Afternoon Meeting Transcripts Project stage: Request ML0703305622007-01-24024 January 2007 Dseis Meeting Presentation, Preliminary Results of Environmental Review Pilgrim Nuclear Power Station Project stage: Request ML0704403552007-01-26026 January 2007 E-MAIL: (PA) Backgrounder.Pdf Project stage: Other ML0704403562007-01-26026 January 2007 E-MAIL: (PA) Scan001 (30).pdf Project stage: Other ML0704403582007-01-26026 January 2007 E-MAIL: (PA) Meteorology/Modeling Considerations for Various NRC Regulatory Licensing Programs Project stage: Other ML0704404022007-01-30030 January 2007 E-MAIL: (PD) Pilgrim SEIS Project stage: Other ML0704404062007-01-31031 January 2007 E-mail: (PD) Pilgrim Follow Up Information Project stage: Other ML0706803512007-02-0707 February 2007 E-MAIL: (PD) Pilgrim Meeting Handouts Project stage: Meeting ML0706803412007-02-15015 February 2007 E-MAIL: (PD) Pilgrim SEIS Project stage: Other ML0710300222007-02-28028 February 2007 E-MAIL: (PA) Response from Comment on NRC Documents Project stage: Other ML0707501272007-03-0101 March 2007 E-MAIL: (PD) Requested Document, Safety Evaluation Report with Open Items Related to the License Renewal of Pilgrim Nuclear Power Station Project stage: Approval ML0710300212007-03-0202 March 2007 E-MAIL: (PA) Pilgrim Nuclear Power Station Deis Comments Project stage: Other ML0710204792007-03-0202 March 2007 E-MAIL: (PA) Distribution of Final Document: Summary of Public Meetings Draft SEIS Pilgrim Project stage: Draft Approval ML0710301912007-03-0505 March 2007 E-MAIL: (PD) Request Hard copy-safety Evaluation Report from Mary Lampert To- phb1@nrc.gov 3/5/07 11:32am Project stage: Other ML0710302112007-03-0606 March 2007 E-MAIL: (PD) Week of 2/26 - Conference Calls from Perry Buckberg to Doug Ellis 3/6/07 9:18am Project stage: Other ML0710302212007-03-0707 March 2007 E-MAIL: (PD) Updated - Week of 2/26 Conference Call Record from Perry Buckberg to Doug Ellis 3/7/07 6:36am Project stage: Other ML0710205082007-03-0808 March 2007 E-MAIL: (PA) 1266 DC Mass Ag Comments on Draft EIS 2-28-07.pdf Project stage: Draft Other ML0710204902007-03-0808 March 2007 E-MAIL: (PA) 1266 DC Mass Ag Comments on Draft EIS 2-28-07.pdf Project stage: Draft Other ML0710204832007-03-12012 March 2007 E-mail: (PA) PNPS License Renewal - Cooling Tower Question Project stage: Other ML0710300422007-03-13013 March 2007 E-MAIL: (PD) Copy of LRA Amendment 15 Letter - from Edward Sanchez to phb1@nrc.gov 3/13/07 12:29pm Project stage: Other ML0710300482007-03-19019 March 2007 E-mail: (PD) Meeting Summary - March 14 & 15 2007 - from Perry Buckberg to Doug Ellis 3/19/07 7:05am Project stage: Meeting ML0710300582007-03-20020 March 2007 E-MAIL: (PD) Pilgrim Lr ACRS Subcommittee (Sc) Meeting on 4/4/07 - from Mairtri Banerjee to Lambros Lois; Perry Buckberg 3/20/07 1:20pm Project stage: Meeting ML0710300632007-03-21021 March 2007 E-MAIL: (PD) Fwd: Meeting Summary - March 14 & 15 2007 - from Perry Buckberg to Doug Ellis 3/21/07 1:04pm Project stage: Meeting ML0710205052007-03-21021 March 2007 E-MAIL: (PA) EPA Suspends 316(b) Rule Project stage: Other ML0710300692007-03-22022 March 2007 E-MAIL: (PD) Dry Well - Event Number: 43245 - from Mary Lampert to Perry Buckberg 3/22/07 9:08am Project stage: Other ML0710301762007-03-27027 March 2007 E-MAIL: (PD) Pilgrim Draft ACRS Presentation - from Bryan Ford to Perry Buckberg 3/27/07 5:25pm Project stage: Draft Other ML0710203452007-03-28028 March 2007 E-MAIL: (PD) Revised Draft ACRS Fluence Slides2 Project stage: Draft Other ML0710202962007-03-28028 March 2007 E-MAIL: (PD) Draft Program Detail Pilgrim ACRS Subcommitte Presentation.Ppt Project stage: Draft Other ML0710202912007-03-28028 March 2007 E-MAIL: (PD) Drywell Project stage: Other ML0710203432007-03-29029 March 2007 E-MAIL: (PD) Revised Draft ACRS Fluence Slides Project stage: Draft Other ML0710203162007-03-29029 March 2007 E-MAIL: (PD) Pdf Copy of Entergy Letter Providing Comments on Draft SER on Pilgrim LRA Project stage: Draft Other ML0710203192007-03-29029 March 2007 E-MAIL: (PD) Entergy-Preliminary Durability Performance Evaluation of Perry Project stage: Other ML0710203672007-03-30030 March 2007 E-MAIL: (PD) People Attending ACRS Sub Committee Meeting Project stage: Meeting ML0710203832007-03-30030 March 2007 E-MAIL: (PD) Final Presentation to Advisory Committee on Reactor Safguards Project stage: Other ML0712001772007-04-0202 April 2007 E-MAIL: (PD) Fw: Revised Drywell UT Table and Annulus Drain VT-2 Datasheets Project stage: Other ML0712001972007-04-0202 April 2007 E-MAIL: (PD) Annulus Drain Line Buckets Project stage: Other ML0712001882007-04-0303 April 2007 E-MAIL: (PD) Conference Call Record 4/2/2007 Project stage: Other ML0712001872007-04-12012 April 2007 E-MAIL: (PD) Conference Call Record 4/2/2007 Project stage: Other ML0712808142007-04-13013 April 2007 E-MAIL: (NPA-PD) Entergy Efh Comment References Doc - Pilgrim Project stage: Other ML0712001792007-04-18018 April 2007 E-MAIL: (PD) Copy of PNPS LRA Annual Update Letter Project stage: Other ML0712901202007-04-19019 April 2007 E-mail: (NPA-PD) Entergy Efh Comment References2 - Pilgrim Project stage: Other ML0712808112007-04-20020 April 2007 E-MAIL: (NPA-PD) Entergy Efh Comment References - Pilgrim Project stage: Other ML0712902982007-04-24024 April 2007 E-MAIL (NPA-PD) Paper Abstract Project stage: Other ML0712903872007-04-25025 April 2007 E-mail (NPA-PD) Additional Info/References: Sea Breeze Journal Article Project stage: Other 2007-03-21
[Table View] |
|
---|
Category:Letter
MONTHYEARML24240A1692024-09-18018 September 2024 Cy 2023 Summary of Decommissioning Trust Fund Status IR 05000293/20240022024-08-21021 August 2024 NRC Inspection Report No. 05000293/2024002 PNP 2024-030, Update Report for Holtec Decommissioning International Fleet Decommissioning Quality Assurance Program Rev. 3 and Palisades Transitioning Quality Assurance Plan, Rev 02024-08-0202 August 2024 Update Report for Holtec Decommissioning International Fleet Decommissioning Quality Assurance Program Rev. 3 and Palisades Transitioning Quality Assurance Plan, Rev 0 ML24151A6482024-06-0303 June 2024 Changes in Reactor Decommissioning Branch Project Management Assignments for Some Decommissioning Facilities ML24129A1042024-05-26026 May 2024 Preapplication Readiness Assessment Plan for the Holtec Decommissioning International License Termination Plan ML24136A2382024-05-14014 May 2024 Annual Radiological Environmental Operating Report for 2023 ML24135A3212024-05-14014 May 2024 Annual Radioactive Effluent Release Report, January 1 Through December 31, 2023 IR 05000293/20240012024-05-0707 May 2024 NRC Inspection Report No. 05000293/2024001 L-24-009, HDI Annual Occupational Radiation Exposure Data Reports - 20232024-04-29029 April 2024 HDI Annual Occupational Radiation Exposure Data Reports - 2023 L-24-010, Request for Preapplication Readiness Assessment of the Draft License Termination Plan2024-04-22022 April 2024 Request for Preapplication Readiness Assessment of the Draft License Termination Plan L-24-007, Report on Status of Decommissioning Funding for Reactors and Independent Spent Fuel Storage Installations – Holtec Decommissioning International, LLC (HDI)2024-03-29029 March 2024 Report on Status of Decommissioning Funding for Reactors and Independent Spent Fuel Storage Installations – Holtec Decommissioning International, LLC (HDI) IR 05000293/20230032024-02-29029 February 2024 NRC Inspection Report Nos. 05000293/2023003 and 05000293/2023004 L-24-002, Late LLRW Shipment Investigation Report Pursuant to 10 CFR 20, Appendix G2024-02-0202 February 2024 Late LLRW Shipment Investigation Report Pursuant to 10 CFR 20, Appendix G ML23342A1182024-01-0909 January 2024 Independent Spent Fuel Storage Installation Security Inspection Plan L-23-019, Proof of Financial Protection 10 CFR 140.152023-12-18018 December 2023 Proof of Financial Protection 10 CFR 140.15 ML23334A1822023-11-30030 November 2023 Biennial Report for the Defueled Safety Analysis Report Update, Technical Specification Bases Changes, 10 CFR 50.59 Evaluation Summary, and Regulatory Commitment Change Summary – November 2021 Through October 2023 L-23-012, Master Decommissioning Trust Agreement Changes for Indian Point Nuclear Generating Units 1, 2 and 3, Pilgrim Nuclear Power Station, Palisades Nuclear Plant and the Non-Qualified Trust for Big Rock Point2023-11-13013 November 2023 Master Decommissioning Trust Agreement Changes for Indian Point Nuclear Generating Units 1, 2 and 3, Pilgrim Nuclear Power Station, Palisades Nuclear Plant and the Non-Qualified Trust for Big Rock Point ML23306A0992023-11-0202 November 2023 and Indian Point Energy Center, Notification of Changes in Schedule in Accordance with 10 CFR 50.82(a)(7) IR 05000293/20234012023-08-31031 August 2023 NRC Inspection Report No. 05000293/2023401 & 2023001 (Cover Letter Only) IR 05000293/20230022023-08-0404 August 2023 NRC Inspection Report No. 05000293/2023002 L-23-008, Correction to Report on Status of Decommissioning Funding for Reactors and Independent Spent Fuel Storage Installations Holtec Decommissioning International, LLC (HDI)2023-05-23023 May 2023 Correction to Report on Status of Decommissioning Funding for Reactors and Independent Spent Fuel Storage Installations Holtec Decommissioning International, LLC (HDI) ML23135A2152023-05-15015 May 2023 Annual Radioactive Effluent Release Report, January 1 Through December 31, 2022 ML23136A7792023-05-15015 May 2023 Annual Radiological Environmental Operating Report, January 1 Through December 31, 2022 L-23-004, HDI Annual Occupational Radiation Exposure Data Reports - 20222023-04-24024 April 2023 HDI Annual Occupational Radiation Exposure Data Reports - 2022 L-23-003, Report on Status of Decommissioning Funding for Reactors and Independent Spent Fuel Storage Installations2023-03-31031 March 2023 Report on Status of Decommissioning Funding for Reactors and Independent Spent Fuel Storage Installations ML23088A0382023-03-29029 March 2023 Stations 1, 2, & 3, Palisades Nuclear Plant, and Big Rock Point - Nuclear Onsite Property Damage Insurance ML23069A2782023-03-13013 March 2023 Request for Scoping Comments Concerning the Environmental Review of Monticello Nuclear Generating Plant, Unit 1 Subsequent License Renewal Application ML22361A1022023-02-24024 February 2023 Reactor Decommissioning Branch Project Management Changes for Some Decommissioning Facilities and Establishment of Backup Project Manager for All Decommissioning Facilities IR 05000293/20220042023-02-15015 February 2023 NRC Inspection Report No. 05000293/2022004 ML22356A0712023-01-31031 January 2023 Issuance of Exemption for Pilgrim Nuclear Power Station ISFSI Regarding Annual Radioactive Effluent Release Report - Cover Letter ML22347A2782022-12-21021 December 2022 Independent Spent Fuel Storage Installation Security Inspection Plan Dated December 21, 2022 L-22-042, Oyster, Pilgrim, Indian Point, Palisades and Big Rock Point - Proof of Financial Protection 10 CFR 140.152022-12-14014 December 2022 Oyster, Pilgrim, Indian Point, Palisades and Big Rock Point - Proof of Financial Protection 10 CFR 140.15 L-22-041, Supplemental Information to Enhance Exemption Request Detail for Pilgrim ISFSI Annual Radioactive Effluent Release Report Due Date Extension2022-12-0909 December 2022 Supplemental Information to Enhance Exemption Request Detail for Pilgrim ISFSI Annual Radioactive Effluent Release Report Due Date Extension IR 05000293/20220032022-11-18018 November 2022 NRC Inspection Report No. 05000293/2022003 L-22-036, Decommissioning Trust Fund Agreement2022-11-0808 November 2022 Decommissioning Trust Fund Agreement ML22276A1762022-10-24024 October 2022 Decommissioning International Proposed Revisions to the Quality Assurance Program Approval Forms for Radioactive Material Packages ML22266A1922022-09-23023 September 2022 and Pilgrim Nuclear Power Station - Request to Withdraw Prior Submissions from NRC Consideration ML22272A0352022-09-22022 September 2022 S. Lynch-Benttinen Letter Regarding U.S. Citizen Intent to Sue U.S. Fish and Wildlife and NOAA Fisheries Representing the Endangered Species (Na Right Whale) Which Will Be Adversely Affected by Holtec International Potential Actions ML22269A4202022-09-22022 September 2022 Citizen Lawsuit ML22241A1122022-08-29029 August 2022 Request for Exemption from 10 CFR 72.212(a)(2), (b)(2), (b)(3), (b)(4), (B)(5)(i), (b)(11), and 72.214 for Pilgrim ISFSI Annual Radioactive Effluent Release Report IR 05000293/20220022022-08-12012 August 2022 NRC Inspection Report No. 05000293/2022002 ML22215A1772022-08-0303 August 2022 Decommissioning International (HDI) Proposed Revisions to the Quality Assurance Program Approval Forms for Radioactive Material Packages ML22221A2592022-08-0101 August 2022 LTR-22-0217-1-NMSS - Town of Duxbury Letter Opposing the Irradiated Water Release from Pilgrim (Docket No. 05000293) ML22206A1512022-08-0101 August 2022 NRC Office of Investigations Case Nos. 1-2022-002 & 1-2022-006 ML22175A1732022-07-28028 July 2022 LTR-22-0153-1 - Response Letter to D. Turco, Cape Downwinders, from A. Roberts, NRC, Regarding Holtec-Pilgrim Plans to Dump One Million Gallons of Radioactive Waste Into Cape Cod Bay ML22193A1662022-07-28028 July 2022 LTR-22-0154-1 - Heather Govern, VP, Clean Air and Water Program, Et Al., Letter Regarding Radioactive Wastewater Disposal from the Pilgrim Nuclear Power Station (Docket No. 05000293) ML22154A4882022-06-0101 June 2022 Letter from Conservation Law Foundation Regarding Irradiated Water Release from Pilgrim ML22154A1622022-05-26026 May 2022 Letter and Email from Save Our Bay/Diane Turco Regarding Irradiated Water Release from Pilgrim ML22136A2602022-05-16016 May 2022 Submittal of Annual Radiological Environmental Operating Report for January 1 Through December 31, 2021 ML22136A2572022-05-16016 May 2022 Submittal of Annual Radioactive Effluent Release Report for January 1 Through December 31, 2021 2024-09-18
[Table view] |
Text
The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619 MITT ROMNEY GOVERNOR KERRY HEALEY LIEUTENANT GOVERNOR TIMOTHY R. MURPHY SECRETARY PAUL J. COTE, JR.COMMISSIONER May 9, 2006 Mary Lampert
Dear Ms. Lampert:
This letter is a response to your recent email to Bob Knorr at the Massachusetts Department of Public Health (MDPH) requesting child health statistics.
Enclosed are data on childhood cancer and low birthweight in Duxbury, Kingston, Marshfield and Plymouth around the Pilgrim Nuclear Power Station. Dr. Knorr forwarded your inquiry to the Community Assessment Program (CAP), a division within the Center for Environmental Health (CEH) at the MDPH, which responds to requests such as yours. Enclosed with this letter please find eight tables that summarize the data we are able to provide to you.Tables 1-3 summarize the incidence of all childhood cancers in four communities (Duxbury, Kingston, Marshfield and Plymouth) during three separate time periods (1982-1988, 1989-1995 and 1996-2002).
Childhood cancer is defined as all invasive, primary cancers diagnosed in children aged 0 to 19 years at diagnosis.
[For an explanation of how the Standardized Incidence Ratio (SIR) was calculated and how to interpret it, please see the attachment entitled Explanation of a Standardized Incidence Ratio (SIR) and 95% Confidence Interval.]
Tables 4-7 are a summary of the different cancer types diagnosed in each time period by town. In a March 2003 MDPH Center for Health Statistics, Research and Evaluation report entitled Childhood Cancer in Massachusetts 1990-1999, the three most common cancers among all Massachusetts children and adolescents less than 20 years old were leukemia (23.8%), lymphomas (18.6%,. which include Hodgkin's disease and other lymphomas), and central nervous system cancers (17.4%, which include brain cancer and other CNS tumors). Similarly, in a 1999 federal report entitled Cancer Incidence and Survival among Children and Adolescents:
United States SEER Program 1975-1995, the highest childhood cancer rates were for leukemia, lymphomas, and brain/CNS cancers.
Table 8 summarizes the percentage of low birthweight babies out of the total number of births in each of the same four communities along with the overall percentage of low birthweight babies for the state for comparison.
Low birthweight is defined as any newborn who weighted less than 2500 grams (5 lbs. 8 oz.) at birth.The following is a summary based upon a review of these data: For 1982-1988, with two exceptions, the number of observed diagnoses of childhood cancers was less than the number expected.
In Marshfield there were five diagnoses of childhood cancer observed in males compared to four expected and in Kingston there were two diagnoses observed in females compared to one expected; however, the differences were not statistically significant.
For 1989-1995, in each of the four communities, in some instances, the number of observed diagnoses exceeded the number expected; the differences; however, were not statistically significant.
In Duxbury females, three diagnoses of childhood cancer were observed versus approximately -two expected.
In Kingston among males and females combined, six diagnoses of childhood.
cancer were observed versus approximately three expected.
In Marshfield, more females were diagnosed with childhood cancer than expected (6 observed versus 3.1 expected) and fewer males were diagnosed than expected (1 observed versus 4.1 expected).
In Plymouth, the number of overall childhood cancers slightly exceeded the number expected (16 observed versus 15.3 expected).
- For 1996-2002, for the three communities of Duxbury, Kingston, and Marshfield, the number of observed diagnoses of childhood cancer was consistently lower than the number expected.
In Plymouth males and females, childhood cancer rates were higher for both males and females. However, the differences were not statistically significant." As seen in Tables 4-7, the types of childhood cancers diagnosed duririg 1982-2002 were generally consistent with state and national trends, with the most common diagnoses of leukemia, Hodgkin's disease, and brain/CNS cancers being consistent with state and national trends. There were a few exceptions.
As seen in Table 4, no childhood diagnoses of brain/CNS cancer were reported in Duxbury over the 21-year time period whereas two diagnoses of bone cancer were reported over a 14-year time period. Also, as seen in Table 6, four diagnoses of bone cancer occurred in Marshfield over the 21-year time period. Finally, as seen in Table 7, three diagnoses of thyroid cancer occurred in Plymouth during the 1996-2002 period. Due to the observation of three thyroid diagnoses in Plymouth during the latest seven-year time period, we evaluated the geographic distribution of their place of residence.
The three individuals with thyroid cancer resided approximately six to 12 miles apart. One individual diagnosed resided in the north of Plymouth, one in the east, and one in the southern portion of Plymouth.2 If you have any questions regarding the information that is enclosed in this letter, please feel free to contact me at (617) 624-5757.Sincerely, Jan Sullivan, Director Community Assessment Program Center for Environmental Health Enclosures CC: Suzanne Condon, Associate Commissioner, MDPH Martha J. Steele, Deputy Director, CEH Bob Knorr, Director, Environmental Epidemiology, CEH 3 TABLE 1 Childhood Cancer Incidence Duxbury, Kingston, Marshfield
& Plymouth, MA 1982-1988 i Town' ~ ~ Total M '~I'ales Females__________________
O>' bsj' Exp rSIR 79~5% CII O~bs~ Ex SIR7 95% CI Obs Ep SR 9%C Duxbury 3 4.5 NC NC --. NC 1 2.4 M NC NC- NC 2 2.0 NC NC -- NC Kingston 2 2.7 NC NC -- NC 0 1.5 NC NC-- NC 2 1.2 -NC NC -- NC Marshfield 7 7.3 96 39 -- 199 5 4.0 126 41 -- 295 2 3.3 NC NC -- NC Plymouth 8 13.6 59 25 --116 4 7.4 NC NC-- NC 4 6.2 NC NC-- NCýNote: SIRs are calculated based on the exact number of expeceted cases, Expcte nmbe o caesp~resented aerounded tothe 4 nearest tenth.SIRs and 95% CI are not calculated when observ~ed numi~ber of 'cases < 5.Ohs = Observed number of cases 195% Cl = 95% Confidence Interval Exp = Expected nu~mber of cases, NC, =,N~~4ot calculated SIR = Standardized Incidence Ratio ><~' ~
- Statistical significance.
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 2 Childhood Cancer Incidence Duxbury, Kingston, Marshfield
& Plymouth, MA 1989-1995 Town .Total i Males 7 ..Females..*
OsObs Exp SIR 95% C 0s Exp:7 SIR , 95% I Obs Exp 7 SIR .95% L/Duxbury 4 4.7 NC NC -- NC 1 2.6 NC NC-- NC 3 2.0 NC NC -- NC Kingston 6 3.0 199 73 -- 432 4 1.7 NC NC-- NC 2 1.3 NC NC -- NC Marshfield 6 7.2 .97 39 -- 200 1 4.1 NC 'NC-- NC 6 3.1 191 70 -- 416 Plymouth 16 15.3 104 60 -- 169 10 8.6 116 56 -- 214 6 6.7 89 33 -- 194 Note: SIRs are, calculated b~ased on the exact ~number of expce ae Expected number of cases presented are roundedto the nearest tenth.SIRs and 95%o CIare not calculated when obseried nhumber of cases < 5.Obs =sObserved number of SESxp =Expectedinumber of case ISIR = Standardiz~ed Incidence Ratio'95% CI =95% Conifidence Interval NC = Not calculated
- =Statistical significance Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE 3 Childhood Cancer Incidence Duxbury, Kingston, Marshfield
& Plymouth, MA 1996-2002 Town~ Total ~Males ~ Females~SObs~ Exp SIR /95% CI >Ob~s ~Exp <SIJI 95% CI Obs~ Exp~ SIR~ 95% CI Duxbury 3 5.1 NC NC --1 2.7 NC NC-- NC 2 2.4 NC NC-- NC Kingston 2.. 3.9 NC NC --NC 0 2.1 NC NC-- NC 2 1.8 NC NC-- NC Marshfield 5 8.2 61 20 -- 143 4 4.4 NC NC-- NC 1 3.8 NC NC-- NC Plymouth 20 16.6 120 74 -- 186 11 8.9 124 62 -- 221 9 7.7 117 53 -- 222 Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
TABLE4 Number of Different Cancer Types Duxbury 1982-2002.>Cancer Time Period S1982ý-119818 1989-1995 1996-2002 Totals Leukemia I -1 Hodgkins 1 -1 Bone -1 1 2 Ovarian I -1 1 Testicular
-1 1 Melanoma 1 -1 AllOther Types 1 2 3 TABLE 5 Number of Different Cancer Types Kingston 1982-2002 Cancer__ Time Period,"~ K1982-19,88, 1989-1995 1996-2002 Totals Leukemia 1 1 -2 Brain/CNS 2 -2 Hodgkins 1 -I Bone -1 1 Ovarian --1. 1 Melanoma -1 1 Stomach 1 -1 TABLE 6 Number of Different Cancer Types Marshfield 1982-2002 Cancer, ".:Time ,P-eriod:,',ý-,ý.", 1982-1988 v1989'-1f99-196202Totals Leukemia 1 --1 Brain/CNS 1 1 1 3 Hodgkins -1 1 2 Bone 2 1 1 4 Thyroid 1 1 Testicular 1 1 Kidney -1 1 All Other Types 1 3 1 5 TABLE 7 Number of Different Cancer Types Plymouth 1982-2002 Cancer Time Period._____________1982-1988 1989-1995~
199~6-2002 Totals Leukemia .2 3 4 9 Brain/CNS 1 3 4 8 Hodgkins 2 2 1 5 Bone 1 Thyroid -3 3 Ovarian 1 1 Oral/Pharynx
-1 1 2 NHL -1 1 2 Kidney -1 1 Larynx 1 -1 Colon/Rectum 1 --1 All Other Types 1 4 5 10 TABLE 8 Percentage of Low Birthweight Babies (<2500 grams) in Total Births Duxbury, Kingston, Marshfield, and Plymouth, MA 1989-2003 Year P juxbury Kington Ma rsbield~ ~Plymouth Massachusetts 1989 3.1 N/At 4.2 3.2 5.9 1990 5.1 5.2 4.8 5.7 5.8 1991 7.0 6.3 3.2 5.4 5.9 1992 5.4 6.3 2.9 4.4 5.9 1993 5.3 5.2 4.0 5.1 6.2 1994 5.0 3.4 4.1 5.3 6.4 1995 3.6 4.2 3.1 4.6 6.3 1996 3.7 4.5 3.0 5.8 6.4 1997 5.2 4.7 5.4 6.2 7.0 1998 N/At 3.6 3.7 4.7 7.0 1999 5.2 8.3 4.7 4.2 7.1 2000 6.9 5.1 5.9 5.9 7.0 2001 4.4 8.6 5.8 5.2 7.2 2002 7.5 3.9 5.3 8.1 7.5 2003 5.6 3.4 4.0 6.3 7.6 tN/A: Not Available due to small numbers and protection of confidentiality.
Data Source: MassCHIP, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Explanation of a Standardized Incidence Ratio (SIR)And 95% Confidence Interval In order to evaluate cancer incidence a statistic known as a standardized incidence ratio (SIR) was calculated for each cancer type. An SIR is an estimate of the occurrence of cancer in a population relative to what might be expected if the population had the same cancer experience as some larger comparison population designated as "normal" or average. Usually, the state as a whole is selected to be the comparison population.
Using the state of Massachusetts as a comparison population provides a stable population base for the calculation of incidence rates. As a result. of the instability of incidence rates based on small numbers of cases, SIRs were not calculated when fewer than five cases were observed.Specifically, an SIR is the ratio of the observed number of cancer cases to the expected number of cases multiplied by 100. An SIR of 100 indicates that the number of cancer cases observed in the population evaluated is equal to the number of cancer cases expected in the comparison or "normal" population.
An SIR greater than 100 indicates that more cancer cases occurred than expected and an SIR less than 100 indicates that fewer cancer cases occurred than expected' Accordingly, an SIR of 150 is interpreted as 50% more cases than the expected number; an SIR of 90 indicates 10% fewer cases than expected.Caution should be exercised, however, when interpreting an SIR. The interpretation of an SIR depends on both the size and the stability of the SIR. Two SIRs can have the same size but not the same stability.
For example, an SIR of 150 based on 4 expected cases and 6 observed cases indicates a 50% excess in cancer, but the excess is actually only two cases. Conversely, an SIR of 150 based on 400 expected cases and 600 observed cases represents the same 50% excess in cancer, but because the SIR is based upon a greater number of cases, the estimate is more stable. It is very unlikely that 200 excess cases of cancer would occur by chance alone.To determine if the observed number of cases is significantly different from the expected number or if the difference may be due solely to chance, a 95% confidence interval (CI) was calculated for each SIR. A 95% CI assesses the magnitude and stability of an SIR. Specifically, a 95% CI is the range of estimated SIR values that has a 95%probability of including the true SIR for the population.
If the 95% CI range does not include the value 100, then the study population is significantly different from the comparison or. "normal" population. "Significantly different" means there is less than 5% percent chance that the observed difference is the result of random fluctuation in the number of observed cancer cases.For example, if a* confidence interval does not include 100 and the interval is above 100 (e.g., 105-130), then there is statistically significant excess in the number of cancer cases. Similarly, if the confidence interval does not include 100 and the interval is below 100 (e.g., 45-96), then the number of cancer cases is statistically significantly 1 Source: Massachusetts Department of Public Health, Center for Environmental Health (December 19.98)
,I lower than expected.
If the confidence interval range includes 100, then the true SIR may be 100, and it cannot be concluded with sufficient confidence that the observed number of cases is not the result of chance and reflects a real cancer increase or. decrease.Statistical significance is not assessed when fewer than five cases are observed.In addition to the range of the estimates contained in the confidence interval, the width of the confidence interval also reflects the stability of the SIR estimate.
For example, a narrow confidence interval (e.g., 103--115) allows a fair level of certainty that the calculated SIR is close to the true SIR for the population.
A wide interval (e.g., 85--450), leaves considerable doubt about the true SIR, which could be much lower than or much higher than the calculated SIR. This would indicate an unstable statistic.
2 Source: Massachusetts Department of Public Health, Center for Environmental Health (December 1998)